ResMed Profit Margin 2006-2018 | RMD

Current and historical gross margin, operating margin and net profit margin for ResMed (RMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ResMed net profit margin as of September 30, 2018 is 13.94%.
ResMed Annual Profit Margins
ResMed Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.239B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $127.843B 25.90
Medtronic (MDT) Ireland $127.434B 19.54
Stryker (SYK) United States $64.080B 24.15
Boston Scientific (BSX) United States $53.415B 26.99
Baxter (BAX) United States $33.780B 21.81
Zimmer Biomet Holdings (ZBH) United States $23.992B 15.56
Smith & Nephew SNATS (SNN) United Kingdom $16.143B 0.00
Canopy Growth (CGC) Canada $9.087B 0.00
Perrigo (PRGO) Ireland $8.704B 13.21
Bio-Rad Laboratories (BIO) United States $8.282B 52.95
Aurora Cannabis (ACB) Canada $7.005B 66.27
Hill-Rom Holdings (HRC) United States $6.451B 20.45
Haemonetics (HAE) United States $5.768B 50.73
Insulet (PODD) United States $5.175B 0.00
ICU Medical (ICUI) United States $4.749B 26.49
Hutchison China MediTech (HCM) China $4.266B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.158B 0.00
Agios Pharmaceuticals (AGIO) United States $4.020B 0.00
Neogen (NEOG) United States $3.320B 50.28
National Vision Holdings (EYE) United States $3.309B 73.08
Aphria (APHA) $3.074B 0.00
NuVasive (NUVA) United States $2.979B 27.72
Quidel (QDEL) United States $2.599B 33.88
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.498B 21.20
AtriCure (ATRC) United States $1.262B 0.00
Cardiovascular Systems (CSII) United States $1.079B 1554.50
VAREX IMAGING (VREX) United States $1.035B 16.91
PetIQ (PETQ) United States $0.874B 28.60
Surmodics (SRDX) United States $0.855B 130.61
Meridian Bioscience (VIVO) United States $0.836B 26.65
OraSure Technologies (OSUR) United States $0.797B 44.86
Cerus (CERS) United States $0.778B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 24.86
MacroGenics (MGNX) United States $0.734B 0.00
Omeros (OMER) United States $0.638B 0.00
Lantheus Holdings (LNTH) United States $0.575B 17.81
Insys Therapeutics (INSY) United States $0.568B 0.00
Owens & Minor (OMI) United States $0.567B 6.41
LeMaitre Vascular (LMAT) United States $0.527B 25.89
NanoString Technologies (NSTG) United States $0.475B 0.00
TG Therapeutics (TGTX) United States $0.459B 0.00
Evolus (EOLS) United States $0.416B 0.00
Quanterix (QTRX) United States $0.372B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.312B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.280B 0.00
BioLife Solutions (BLFS) United States $0.258B 348.50
Surface Oncology (SURF) United States $0.227B 0.00
Rockwell Medical (RMTI) United States $0.225B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.162B 0.00
Fonar (FONR) United States $0.143B 7.20
Chembio Diagnostics (CEMI) United States $0.117B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.60
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Valeritas Holdings (VLRX) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00